Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Pyknoachondrogenesis is a lethal skeletal osteochondrodysplasia characterized by severe generalized osteosclerosis.
Features include: Increased bone density (increased bone mineral density).
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Increased bone density (increased bone mineral density) |
Biomarker and diagnostic research for pyknoachondrogenesis has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for pyknoachondrogenesis.
97 publications have been identified in PubMed for pyknoachondrogenesis. Kisho has analyzed 66 by research type. Research spans Basic Science / Preclinical (23%), Epidemiology / Natural History (20%), and Review / Meta-Analysis (15%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 15 | 23% |
Data assembled from 5 of 12 sources · Last updated Sep 18, 2026, 2:27 AM UTC
Patient Advocacy Groups (PAGs) provide support, resources, and community for patients and caregivers.
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Disease patterns and progression
13 |
20% |
Research summaries | 10 | 15% |
Patient case studies | 10 | 15% |
Testing and diagnosis research | 9 | 14% |
Clinical study results | 7 | 11% |
New treatment approaches | 2 | 3% |
Lo Prinzi F (2026). [PMID: 41268659](https://pubmed.ncbi.nlm.nih.gov/41268659/). *Hepatol Res*. [Epidemiology / Natural History]
Camera M (2026). [PMID: 42214306](https://pubmed.ncbi.nlm.nih.gov/42214306/). *Curr Opin Immunol*. [Review / Meta-Analysis]
Camera M (2026). [PMID: 40605716](https://pubmed.ncbi.nlm.nih.gov/40605716/). *Haematologica*. [Basic Science / Preclinical]
Higashida M (2026). [PMID: 41107688](https://pubmed.ncbi.nlm.nih.gov/41107688/). *Surg Today*. [Basic Science / Preclinical]
Koc ER (2026). [PMID: 41504930](https://pubmed.ncbi.nlm.nih.gov/41504930/). *J Neurol*. [Epidemiology / Natural History]
Zhang C (2026). [PMID: 41994629](https://pubmed.ncbi.nlm.nih.gov/41994629/). *Front Oncol*. [Review / Meta-Analysis]
Oh J (2026). [PMID: 41495401](https://pubmed.ncbi.nlm.nih.gov/41495401/). *Nat Med*. [Epidemiology / Natural History]
Vismara M (2026). [PMID: 40459816](https://pubmed.ncbi.nlm.nih.gov/40459816/). *Geroscience*. [Basic Science / Preclinical]
GBD 2023 Vaccine Coverage Collaborators (2025). [PMID: 40578370](https://pubmed.ncbi.nlm.nih.gov/40578370/). *Lancet*. [Epidemiology / Natural History]
GBD 2021 Global Sepsis Collaborators (2025). [PMID: 41135560](https://pubmed.ncbi.nlm.nih.gov/41135560/). *Lancet Glob Health*. [Epidemiology / Natural History]